CLINICAL_TRIALS
trial_result
· 2017-10-31
Clinical Trial Update: Vilazodone for Separation Anxiety Disorder [Phase 4]
Summary
A Phase 4 trial evaluating vilazodone for separation anxiety disorder has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: New York State Psychiatric Institute | Conditions: Separation Anxiety Disorder | Phase 4 | Status: COMPLETED | Results posted: 2017-10-31